We invite you to join our next free webinar titled “Rare Cancers: Recommendations for Oncology Clinical Development” on 30th of June.
Sponsors must be able to balance the need for efficiency and inclusivity on the path to seeking drug approval for rare cancer. Focusing on this topic, our oncology experts will share valuable insights and strategies for developing and operationalizing clinical trials in this space in this free educational webinar.
You can choose between one of 3 sessions available for this webinar:
- Session 1: 30 Jun, 6am EDT / 11am BST / 12pm CEST
- Session 2: 30 Jun, 10am EDT / 3pm BST / 4pm CEST
- Session 3: 30 Jun, 2pm EDT / 7pm BST / 8pm CEST
- Defining what rare cancer means
- Considerations for protocol design- including patient-reported outcomes (PRO)
- Evolving approaches to feasibility
- Strategies for operational delivery
At the end of the webinar, you will have the opportunity to ask our experts any questions you may have.
About our expert speakers
Senior Vice President, Oncology Strategy & Innovation, Ergomed
Debra Kientop is an experienced, strategic leader in oncology clinical development across Pharma, Biotech, and CRO industries. She has focus on patient-centricity and incorporating innovative solutions into clinical delivery. Her role is strategic and executive oversight of clinical trials, sponsors, and KOL engagement.
Senior Vice President, Global Medical Affairs, Ergomed
Dr. Marie-Edith A. Bonneterre is based in Lille, France, and is board-certified in Medical Oncology. Her experience in both the hospital setting and the pharma industry, biotechnology, and CRO arenas is focused on clinical development and innovative strategies. Her role is strategic and medical oversight of clinical trials, and innovative development strategies.
If you have any questions about our webinar please feel free to contact us